Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ

Peroxisome proliferator-activated receptors (PPARs) α and γ are key regulators of lipid homeostasis and are activated by a structurally diverse group of compounds including fatty acids, eicosanoids, and hypolipidemic drugs such as fibrates and thiazolidinediones. While thiazolidinediones and 15-deoxy-Δ12,14-prostaglandin J2 have been shown to bind to PPARγ, it has remained unclear whether other activators mediate their effects through direct interactions with the PPARs or via indirect mechanisms. Here, we describe a novel fibrate, designated GW2331, that is a high-affinity ligand for both PPARα and PPARγ. Using GW2331 as a radioligand in competition binding assays, we show that certain mono- and polyunsaturated fatty acids bind directly to PPARα and PPARγ at physiological concentrations, and that the eicosanoids 8(S)-hydroxyeicosatetraenoic acid and 15-deoxy-Δ12,14-prostaglandin J2 can function as subtype-selective ligands for PPARα and PPARγ, respectively. These data provide evidence that PPARs serve as physiological sensors of lipid levels and suggest a molecular mechanism whereby dietary fatty acids can modulate lipid homeostasis.

[1]  G. Franceschini,et al.  Effects of fibrates on serum lipids and atherosclerosis. , 1988, Pharmacology & therapeutics.

[2]  A. Mahfoudi,et al.  Xenopus peroxisome proliferator activated receptors: Genomic organization, response element recognition, heterodimer formation with retinoid X receptor and activation by fatty acids , 1993, The Journal of Steroid Biochemistry and Molecular Biology.

[3]  S M Grundy,et al.  Dietary influences on serum lipids and lipoproteins. , 1990, Journal of lipid research.

[4]  J. Carrino,et al.  Transcription regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[5]  W. Wahli,et al.  Peroxisome proliferator-activated receptors: finding the orphan a home , 1994, Molecular and Cellular Endocrinology.

[6]  T. Pineau,et al.  Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators , 1995, Molecular and cellular biology.

[7]  J. Gustafsson,et al.  A systematic analytical chemistry/cell assay approach to isolate activators of orphan nuclear receptors from biological extracts: characterization of peroxisome proliferator-activated receptor activators in plasma. , 1993, Journal of lipid research.

[8]  H. Kammermeier,et al.  A one-vial method for routine extraction and quantification of free fatty acids in blood and tissue by HPLC. , 1988, Analytical biochemistry.

[9]  O. Mcbride,et al.  cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor. , 1993, Biochemistry.

[10]  D. Keppler,et al.  Activation of gene transcription by prostacyclin analogues is mediated by the peroxisome-proliferators-activated receptor (PPAR). , 1996, European journal of biochemistry.

[11]  A. Mahfoudi,et al.  Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Rao,et al.  Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver. , 1993, The Journal of biological chemistry.

[13]  J. Gustafsson,et al.  Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Olefsky,et al.  Thiazolidinediones in the Treatment of Insulin Resistance and Type II Diabetes , 1996, Diabetes.

[15]  E. Besemfelder,et al.  Generation of the arachidonic acid metabolite 8-HETE by extracts of mouse skin treated with phorbol ester in vivo; identification by 1H-n.m.r. and GC-MS spectroscopy. , 1986, Carcinogenesis.

[16]  Christine Dreyer,et al.  Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors , 1992, Cell.

[17]  I. Issemann,et al.  Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators , 1990, Nature.

[18]  J. Lehmann,et al.  A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation , 1995, Cell.

[19]  D. Horrobin Abnormal membrane concentrations of 20 and 22-carbon essential fatty acids: a common link between risk factors and coronary and peripheral vascular disease? , 1995, Prostaglandins, leukotrienes, and essential fatty acids.

[20]  K. Umesono,et al.  Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Lehmann,et al.  An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ) (*) , 1995, The Journal of Biological Chemistry.

[22]  B. Ludvik,et al.  Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. , 1994, The New England journal of medicine.

[23]  B. Spiegelman,et al.  mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. , 1994, Genes & development.

[24]  E. Besemfelder,et al.  Characterization of an 8-lipoxygenase activity induced by the phorbol ester tumor promoter 12-O-tetradecanoylphorbol-13-acetate in mouse skin in vivo. , 1991, The Journal of biological chemistry.

[25]  P. Nestel Effects of N-3 fatty acids on lipid metabolism. , 1990, Annual review of nutrition.

[26]  B. Spiegelman,et al.  Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor , 1994, Cell.

[27]  Kai Yu,et al.  Differential Activation of Peroxisome Proliferator-activated Receptors by Eicosanoids (*) , 1995, The Journal of Biological Chemistry.

[28]  A. Brash,et al.  Investigation of the mechanism of biosynthesis of 8-hydroxyeicosatetraenoic acid in mouse skin. , 1991, Biochimica et biophysica acta.

[29]  B. Spiegelman,et al.  Differential activation of adipogenesis by multiple PPAR isoforms. , 1996, Genes & development.

[30]  A. Goodridge,et al.  Physiological and molecular mechanisms involved in nutritional regulation of fatty acid synthesis. , 1995, Physiological reviews.

[31]  I. Issemann,et al.  The peroxisome proliferator-activated receptor:retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs. , 1993, Journal of molecular endocrinology.

[32]  G. Ailhaud,et al.  Fatty acids as signal transducing molecules: involvement in the differentiation of preadipose to adipose cells. , 1994, Journal of lipid research.

[33]  D. Chisholm,et al.  The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. , 1993, The New England journal of medicine.

[34]  W. Wahli,et al.  The PPARα–leukotriene B4 pathway to inflammation control , 1996, Nature.

[35]  E. Kraegen,et al.  Fish oil prevents insulin resistance induced by high-fat feeding in rats. , 1987, Science.

[36]  M. Lazar,et al.  Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation. , 1994, Endocrinology.